X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (196) 196
humans (185) 185
oncology (142) 142
lung neoplasms - genetics (132) 132
eml4-alk fusion gene (126) 126
lung cancer (111) 111
female (93) 93
carcinoma, non-small-cell lung - genetics (87) 87
adenocarcinoma (86) 86
crizotinib (86) 86
lung cancer, non-small cell (86) 86
cancer (84) 84
anaplastic lymphoma kinase (83) 83
middle aged (82) 82
immunohistochemistry (81) 81
male (81) 81
eml4-alk (78) 78
receptor protein-tyrosine kinases - genetics (77) 77
identification (76) 76
mutation (74) 74
oncogene proteins, fusion - genetics (73) 73
alk (71) 71
lung neoplasms - pathology (67) 67
aged (66) 66
lymphomas (65) 65
adult (63) 63
egfr (62) 62
genetic aspects (58) 58
pathology (57) 57
gene rearrangement (56) 56
lung neoplasms - drug therapy (54) 54
tumors (54) 54
adenocarcinoma - genetics (52) 52
mutations (52) 52
in situ hybridization, fluorescence (51) 51
chemotherapy (47) 47
research (47) 47
respiratory system (47) 47
carcinoma, non-small-cell lung - drug therapy (46) 46
hemic and lymphatic diseases (46) 46
aged, 80 and over (41) 41
carcinoma, non-small-cell lung - pathology (41) 41
non-small cell lung cancer (40) 40
nsclc (40) 40
care and treatment (39) 39
health aspects (38) 38
lung neoplasms - diagnosis (38) 38
eml4-alk fusion (37) 37
kinases (37) 37
protein kinase inhibitors - therapeutic use (36) 36
inhibitor (34) 34
lung neoplasms - metabolism (33) 33
adenocarcinoma - pathology (31) 31
gefitinib (31) 31
genes (31) 31
features (30) 30
cell lung-cancer (29) 29
receptor protein-tyrosine kinases - metabolism (29) 29
animals (28) 28
gene (28) 28
hematology, oncology and palliative medicine (28) 28
non-small cell lung carcinoma (28) 28
pyridines - therapeutic use (28) 28
analysis (27) 27
pyrazoles - therapeutic use (27) 27
receptor, epidermal growth factor - genetics (27) 27
epidermal growth factor (26) 26
tyrosine (26) 26
proteins (25) 25
neoplasm staging (24) 24
prognosis (24) 24
diagnosis (23) 23
fish (23) 23
fluorescence in situ hybridization (23) 23
lung-cancer (23) 23
antineoplastic agents - therapeutic use (22) 22
biomarkers, tumor - genetics (22) 22
cancer therapies (22) 22
carcinoma, non-small-cell lung - diagnosis (22) 22
carcinoma, non-small-cell lung - metabolism (22) 22
lung neoplasms - enzymology (22) 22
oncogene proteins, fusion - metabolism (22) 22
proto-oncogene proteins - genetics (22) 22
patients (21) 21
pulmonary/respiratory (21) 21
development and progression (20) 20
growth-factor receptor (20) 20
lymphoma (20) 20
receptor tyrosine kinase (20) 20
translocation, genetic (20) 20
article (19) 19
fluorescence (19) 19
medicine (19) 19
metastasis (19) 19
rearrangement (19) 19
carcinoma (18) 18
drug therapy (18) 18
gene mutations (18) 18
multidisciplinary sciences (18) 18
polymerase chain reaction (18) 18
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 10/2008, Volume 14, Issue 20, pp. 6618 - 6624
Journal Article
Oncotarget, ISSN 1949-2553, 01/2016, Volume 7, Issue 1, pp. 1066 - 1075
Journal Article
Journal Article
ONCOTARGET, 01/2016, Volume 7, Issue 1, pp. 1066 - 1075
Purpose: Non-small-cell lung cancers harboring EML4-ALK rearrangements are sensitive to crizotinib. However, despite initial response, most patients will... 
1ST-LINE TREATMENT | NSCLC | RNA | ANGIOGENESIS | MECHANISM | OPEN-LABEL | platelets | CHEMOTHERAPY | CELL BIOLOGY | EML4-ALK | diagnostics | liquid biopsies | EXOSOMES | MUTATIONS | PROTEINS | TUMOR-GROWTH
Journal Article
Human Pathology, ISSN 0046-8177, 2009, Volume 40, Issue 8, pp. 1152 - 1158
Journal Article
INTERNATIONAL JOURNAL OF HEMATOLOGY, ISSN 0925-5710, 04/2016, Volume 103, Issue 4, pp. 399 - 408
Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK+LBCL) is a rare, aggressive B-cell lymphoma with ALK fusion genes. Histopathologically, the ALK... 
Immunohistochemistry | NPM-ALK | EXTRAMEDULLARY PLASMACYTOMA | KINASE | ANAPLASTIC LYMPHOMA | FUSION TRANSCRIPT | CLINICOPATHOLOGICAL ENTITY | Fusion partner | EML4-ALK | LUNG-CANCER | GENE | Anaplastic lymphoma kinase-positive large B-cell lymphoma | INFLAMMATORY MYOFIBROBLASTIC TUMOR | CRIZOTINIB | HEMATOLOGY | Anaplastic lymphoma kinase
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 43, pp. 75400 - 75410
Background: Anaplastic lymphoma kinase (ALK) gene fusion has been reported in 3 similar to 5% non-small cell lung carcinoma (NSCLC) patients, and polymerase... 
Polymerase chain reaction | Systematic review | Carcinoma | Non-small cell lung | Anaplastic lymphoma kinase | CELL LUNG-CANCER | EML4-ALK FUSION TRANSCRIPTS | SPECIMENS | ASSAY | carcinoma | anaplastic lymphoma kinase | POLYMERASE CHAIN-REACTION | systematic review | polymerase chain reaction | non-small cell lung | IMMUNOHISTOCHEMISTRY | CELL BIOLOGY
Journal Article
Journal Article